# PSMAgRT (NCT03525288)

> PSMA-PET Guided Radiotherapy

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: high-risk, recurrent or oligometastatic prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03525288
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- Conditions: Prostate Cancer
- Interventions: PSMA -PET/CT simulation; Standard-care simulation
- Enrollment: 130
- Primary outcome: Failure-free survival

## Indexed commentary on PSMAgRT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=psmagrt-nct03525288